Outcomes of Large B-Cell Lymphoma Patients By Post CAR-T Salvage Regimen at a Single Institution

被引：2
|
作者：
Sigmund, Audrey M. [1 ]
Denlinger, Nathan [1 ]
Bajwa, Amneet [2 ]
Elder, Patrick [1 ]
Bond, David A. [1 ]
Brammer, Jonathan E. [1 ]
Saad, Ayman [1 ]
Penza, Sam [1 ]
de Lima, Marcos J. G. [1 ]
Jaglowski, Samantha [1 ]
Kittai, Adam S. [1 ]
机构：
[1] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH USA
[2] Ohio State Univ, Div Hosp Med, Dept Internal Med, Columbus, OH USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148751
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3851
引用
收藏
页码：3851 / +
页数：5
相关论文
共 50 条
  • [41] Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium
    Spiegel, Jay Y.
    Jain, Michael D.
    Nastoupil, Loretta J.
    Tamaresis, John
    Ghobadi, Armin
    Lin, Yi
    Lekakis, Lazaros J.
    Reagan, Patrick M.
    Oluwole, Olalekan O.
    McGuirk, Joseph P.
    Deol, Abhinav
    Dorritie, Kathleen
    Sehgal, Alison R.
    Goy, Andre
    Hill, Brian T.
    Andreadis, Charalambos
    Munoz, Javier L.
    Ulrickson, Matthew L.
    Westin, Jason
    Chavez, Julio C.
    Patel, Dilan A.
    Jacobs, Miriam T.
    Bansal, Radhika
    Bennani, N. Nora
    Patel, Vivek
    Rapoport, Aaron P.
    Vose, Julie M.
    Miklos, David B.
    Neelapu, Sattva S.
    Locke, Frederick L.
    Lunning, Matthew A.
    Dahiya, Saurabh
    BLOOD, 2023, 142
  • [42] Advanced laboratory techniques in diffuse large B-cell lymphoma treated with CAR-T: the role for pathologists
    Michaels, Phillip D.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2024, 9 (01): : 25 - 28
  • [43] Genomic Drivers of Large B-Cell Lymphoma Resistance to CD19 CAR-T Therapy
    Jain, Michael D.
    Ziccheddu, Bachisio
    Coughlin, Caroline A.
    Faramand, Rawan
    Griswold, Anthony J.
    Reid, Kayla M.
    Landgren, Ola
    Locke, Frederick L.
    Maura, Francesco
    Davila, Marco L.
    Schatz, Jonathan H.
    BLOOD, 2021, 138
  • [44] CAR-T cell lessons and news: Focus on large B-cell lymphomas
    Dutari, Pilar
    Brisou, Gabriel
    HEMATOLOGIE, 2024, 30 : 14 - 28
  • [45] Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma
    Kuhnl, Andrea
    Roddie, Claire
    Kirkwood, Amy A.
    Menne, Tobias
    Cuadrado, Maria
    Marzolini, Maria A. V.
    Osborne, Wendy
    Sanderson, Robin
    O'Reilly, Maeve
    Townsend, William
    Benjamin, Reuben
    Potter, Victoria
    Patten, Piers E. M.
    Yallop, Deborah
    Voo, Stefan
    Petrides, George S.
    Mulholland, Nicola
    Kayani, Irfan
    BLOOD ADVANCES, 2022, 6 (01) : 321 - 326
  • [46] GENOMIC DRIVERS OF LARGE B-CELL LYMPHOMA RESISTANCE TO CD19 CAR-T THERAPY
    Jain, Michael
    Ziccheddu, Bachisio
    Coughlin, Caroline
    Faramand, Rawan
    Griswold, Anthony
    Reid, Kayla
    Landgren, Ola
    Locke, Frederick
    Maura, Francesco
    Davila, Marco
    Schatz, Jonathan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A703 - A703
  • [47] Characterization of RHOA inactivation as a driver of CAR-T therapy resistance in diffuse large B-cell lymphoma
    Newsam, Austin
    Goretsky, Yitzhar
    Roberts, Evan
    Bilbao, Daniel
    Schatz, Jonathan
    CANCER RESEARCH, 2023, 83 (07)
  • [48] Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium
    Jain, Michael D.
    Jacobs, Miriam T.
    Gao, Feng
    Nastoupil, Loretta J.
    Spiegel, Jay Y.
    Lin, Yi
    Dahiya, Saurabh
    Lunning, Matthew
    Lekakis, Lazaros
    Reagan, Patrick
    Oluwole, Olalekan
    McGuirk, Joseph
    Deol, Abhinav
    Sehgal, Alison R.
    Goy, Andre
    Hill, Brian T.
    Andreadis, Charalambos
    Munoz, Javier
    Chavez, Julio C.
    Bennani, N. Nora
    Rapoport, Aaron P.
    Vose, Julie M.
    Miklos, David
    Neelapu, Sattva S.
    Locke, Frederick L.
    Ghobadi, Armin
    BLOOD ADVANCES, 2024, 8 (04) : 1042 - 1050
  • [49] Characteristics of premanufacture CD8+T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
    Wang, Yao
    Tong, Chuan
    Lu, Yuting
    Wu, Zhiqiang
    Guo, Yelei
    Liu, Yang
    Wei, Jianshu
    Wang, Chunmeng
    Yang, Qingming
    Han, Weidong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [50] Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
    Yao Wang
    Chuan Tong
    Yuting Lu
    Zhiqiang Wu
    Yelei Guo
    Yang Liu
    Jianshu Wei
    Chunmeng Wang
    Qingming Yang
    Weidong Han
    Signal Transduction and Targeted Therapy, 8
12345